Table 1.
Test | Markers | Sensitivity* | Specificity* |
---|---|---|---|
Cytology | Urothelial cells | 30-92% | 93-97% |
ImmunoCyt | Urothelial cell and immunostain | 55-90% | 33-87% |
Urovysion | FISH | 51-92% | 55-95% |
BTA stat (point-of-care) and BTA-TRAK | Bladder Tumor Antigen | 36-91% | 50-90% |
BladderCheck (point-of-care) and Bladder Cancer Test | NMP22 | 34-95% | 55-85% |
ACCU-DX (point-of-care) | FDP | 60-83% | 80-86% |
Vary between low grade and high grade urothelial carcinoma.